Christoph Heining

3.1k total citations
29 papers, 567 citations indexed

About

Christoph Heining is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Christoph Heining has authored 29 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Christoph Heining's work include Cancer Genomics and Diagnostics (11 papers), Lung Cancer Treatments and Mutations (10 papers) and HER2/EGFR in Cancer Research (6 papers). Christoph Heining is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Lung Cancer Treatments and Mutations (10 papers) and HER2/EGFR in Cancer Research (6 papers). Christoph Heining collaborates with scholars based in Germany, Austria and United States. Christoph Heining's co-authors include Hanno Glimm, Peter Schirmacher, Anthony D. Ho, Roland Penzel, Marc S. Raab, David Capper, Andreas von Deimling, Thorsten Zenz, Nicola Lehners and Hartmut Goldschmidt and has published in prestigious journals such as Annals of Oncology, Cancer Discovery and Leukemia.

In The Last Decade

Christoph Heining

26 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Heining Germany 9 246 240 183 127 118 29 567
Antonio Cusmai Italy 11 292 1.2× 197 0.8× 126 0.7× 124 1.0× 109 0.9× 28 577
Isabel Marugán Spain 15 273 1.1× 177 0.7× 145 0.8× 84 0.7× 150 1.3× 29 620
Luigia Monitillo Italy 8 121 0.5× 134 0.6× 151 0.8× 42 0.3× 82 0.7× 16 497
Honghui Huang China 14 123 0.5× 183 0.8× 76 0.4× 43 0.3× 137 1.2× 37 471
Leylah Drusbosky United States 13 223 0.9× 198 0.8× 105 0.6× 183 1.4× 188 1.6× 72 522
Hong Xie United States 13 406 1.7× 338 1.4× 252 1.4× 91 0.7× 65 0.6× 29 739
Olugbenga Olowokure United States 14 269 1.1× 162 0.7× 44 0.2× 156 1.2× 98 0.8× 35 513
Srinivas K. Tantravahi United States 11 173 0.7× 245 1.0× 199 1.1× 242 1.9× 125 1.1× 70 597
IE Smith United Kingdom 6 257 1.0× 228 0.9× 121 0.7× 121 1.0× 230 1.9× 9 577
T Yoshikubo Japan 9 453 1.8× 168 0.7× 90 0.5× 156 1.2× 174 1.5× 16 765

Countries citing papers authored by Christoph Heining

Since Specialization
Citations

This map shows the geographic impact of Christoph Heining's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Heining with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Heining more than expected).

Fields of papers citing papers by Christoph Heining

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Heining. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Heining. The network helps show where Christoph Heining may publish in the future.

Co-authorship network of co-authors of Christoph Heining

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Heining. A scholar is included among the top collaborators of Christoph Heining based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Heining. Christoph Heining is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schlenk, Richard F., Małgorzata Oleś, Sebastian Bauer, et al.. (2023). 1940P Deep molecular profiling of advanced synovial sarcoma as a basis for interventional clinical trials. Annals of Oncology. 34. S1042–S1042.
2.
Hanf, Dorothea, Christoph Heining, Sebastian Uhrig, et al.. (2021). Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient WithETV6-NTRK3Fusion-Positive Carcinoma Harboring theNTRK3G623RSolvent-Front Mutation. JCO Precision Oncology. 5(5). 687–694. 4 indexed citations
3.
Berger, Anne, Sadaf S. Mughal, Michael Allgäuer, et al.. (2020). Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare disease. Pancreatology. 20(3). 425–432. 17 indexed citations
4.
Loosen, Sven H., Nadine T. Gaisa, Maximilian Schmeding, et al.. (2020). Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-Cholangiocarcinoma. Case Reports in Gastroenterology. 14(3). 658–667. 3 indexed citations
5.
Laskin, Janessa, Stephen V. Liu, Khaled Tolba, et al.. (2020). NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents. Annals of Oncology. 31(12). 1693–1703. 93 indexed citations
6.
Weinberg, Benjamin A., Daniel J. Renouf, Howard J. Lim, et al.. (2019). NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option. Annals of Oncology. 30. iv80–iv80. 3 indexed citations
7.
Möck, Andreas, Christoph E. Heilig, Simon Kreutzfeldt, et al.. (2019). Community-driven development of a modified progression-free survival ratio for precision oncology trials. Annals of Oncology. 30. vii28–vii28. 2 indexed citations
8.
Apostolidis, Leonidas, Simon Kreutzfeldt, Małgorzata Oleś, et al.. (2018). Prospective genome and transcriptome sequencing in advanced-stage neuroendocrine neoplasms. Annals of Oncology. 29. viii468–viii468. 1 indexed citations
9.
Perera‐Bel, Júlia, Barbara Hutter, Christoph Heining, et al.. (2018). From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards. Genome Medicine. 10(1). 18–18. 27 indexed citations
10.
Heining, Christoph, Peter Horak, Stefan Gröschel, Hanno Glimm, & Stefan Fröhling. (2017). Personalisierte Onkologie. Der Radiologe. 57(10). 804–811. 3 indexed citations
11.
Fröhling, Stefan, Thomas F.E. Barth, Stefan Gröschel, et al.. (2017). CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT PMO-1601). Annals of Oncology. 28. v538–v538. 2 indexed citations
12.
Czink, Elena, Christoph Heining, Theresia Weber, et al.. (2016). Dauerhafte Remission unter dualer HER2-Blockade mit Trastuzumab und Pertuzumab bei metastasiertem Gallenblasenkarzinom. Zeitschrift für Gastroenterologie. 54(5). 426–430. 15 indexed citations
13.
Heining, Christoph & Christof von Kalle. (2016). Zukünftige Aufgaben onkologischer Spitzenzentren in der Forschung. Der Onkologe. 22(3). 152–157. 2 indexed citations
14.
Kordes, Maximilian, Michael Röring, Christoph Heining, et al.. (2015). Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling. Leukemia. 30(4). 937–946. 34 indexed citations
15.
Andrulis, Mindaugas, Nicola Lehners, David Capper, et al.. (2013). Targeting the BRAF V600E Mutation in Multiple Myeloma. Cancer Discovery. 3(8). 862–869. 171 indexed citations
16.
Heining, Christoph, Wolfgang Hiddemann, Carsten Bokemeyer, & Christof von Kalle. (2013). Charakteristika von CCCs und deren Netzwerk in Deutschland. Forum. 28(4). 231–235. 2 indexed citations
17.
Heining, Christoph & Christof von Kalle. (2012). Translationale Onkologie – Effiziente Umsetzung onkologischer Grundlagenforschung. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 137(1). 1–3. 3 indexed citations
18.
19.
20.
Heining, Christoph, Alexandros Spyridonidis, Jürgen Schulte‐Mönting, et al.. (2007). Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients. Bone Marrow Transplantation. 39(10). 613–622. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Cusmai Breakdown of academic impact, for papers by Isabel Marugán Breakdown of academic impact, for papers by Luigia Monitillo Breakdown of academic impact, for papers by Honghui Huang Breakdown of academic impact, for papers by Leylah Drusbosky Breakdown of academic impact, for papers by Hong Xie Breakdown of academic impact, for papers by Olugbenga Olowokure Breakdown of academic impact, for papers by Srinivas K. Tantravahi Breakdown of academic impact, for papers by IE Smith Breakdown of academic impact, for papers by T Yoshikubo
Rankless by CCL
2026